Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

KemPharm And The Curious Case Of Launching A Brand Opioid Like A Generic

Feb 26 2018

• By Jessica Merrill

PillChart_1200x675

Related Content

Egalet's Bid For Arymo ER Intranasal Abuse-Deterrence Claim Blocked By MorphaBond Exclusivity

Jan 11 2017

KemPharm's Opioid Apadaz Will Likely Miss Out On Abuse Deterrence Claim

May 06 2016

Can KemPharm's Apadaz Meet FDA Opioid Abuse Deterrent Standards?

Jun 14 2016

The Best Bad Deal of All Time? Pfizer/King and the Business Dynamics of Abuse Deterrence

May 30 2013

Related Companies

Zevra Therapeutics, Inc.

Pfizer Inc.

King Pharmaceuticals, Inc.

Zyla Life Sciences

Collegium Pharmaceutical, Inc.

Purdue Pharma L.P.

Teva Pharmaceutical Industries Ltd.

Additional Topics

Launches Generic Drugs Commercial Neurology BioPharmaceutical

More from Products

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window